TULA in recurrent non ‐muscle invasive bladder cancer

Recent NICE guidance says there is limited evidence for the efficacy of transurethral laser ablation for recurrent non ‐muscle invasive bladder cancer and that ‘special arrangements’ need to be in place if it is to be offered to patients. Here the authors consider the advantages and drawbacks of the treatment.
Source: Trends in Urology and Men's Health - Category: Urology & Nephrology Authors: Tags: NICE guidance Source Type: research

Related Links:

Publication date: September 2020Source: Urology Case Reports, Volume 32Author(s): Chawin Sukapiriya, Chanyoot Bandidwattanawong
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
Circular RNAs (circRNAs) have been associated with bladder cancer (BC), but the specific underlying molecular mechanism of their association with BC development has not been fully explored.
Source: Journal of Experimental and Clinical Cancer Research - Category: Cancer & Oncology Authors: Tags: Research Source Type: research
ConclusionWe presented a single case report demonstrating the power of scRNA-seq for visualizing the tumor microenvironment and identifying molecular and cellular therapeutic targets in a treatment-refractory cancer patient.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research
Source: OncoTargets and Therapy - Category: Cancer & Oncology Tags: OncoTargets and Therapy Source Type: research
Conditions:   Quadratus Lumborum Block;   Transversus Abdominis Plane Block;   Bladder Cancer;   Postoperative Pain;   Surgery Interventions:   Procedure: Quadratus lumborum block;   Procedure: Transversus abdominis plane block;   Drug: Intravenous opioid Sponsor:   National Cancer Institute, Egypt Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
AbstractPhotodynamic technology using light-sensitive and fluorescent substances has an important role in an accurate diagnosis for a variety of malignancies, including bladder cancer and prostate cancer. Light-sensitive and fluorescent substances accumulate specifically in tumor cells compared to normal tissue, and by light irradiation and excitation at each specific wavelength, tumor lesion, blood flow, lymph node and so on show fluorescence. 5-Aminolevulinic acid (ALA) is converted to protoporphyrin IX (PpIX) into mitochondria. PpIX is excited by blue light, red fluorescence is emitted in the mitochondria. This phenomen...
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
AbstractThis systematic review and meta-analysis aimed to assess the prognostic value of preoperative hematologic biomarkers in patients with urothelial carcinoma of the bladder treated with radical cystectomy.  PUBMED, Web of Science, Cochrane Library, and Scopus databases were searched in September 2019 according to the Preferred Reporting Items for Systematic Review and Meta-analysis statement. Studies were deemed eligible if they compared cancer-specific survival in patients with urothelial carcinoma of the bladder with and without pretreatment laboratoryabnormalities. Formal meta-analyses were performed for this ...
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 24 May 2020Source: Pathology - Research and PracticeAuthor(s): Tania Franceschini, Elisa Capizzi, Francesco Massari, Riccardo Schiavina, Michelangelo Fiorentino, Francesca Giunchi
Source: Pathology Research and Practice - Category: Pathology Source Type: research
Conditions:   Quadratus Lumborum Block;   Transversus Abdominis Plane Block;   Bladder Cancer;   Postoperative Pain;   Surgery Interventions:   Procedure: Quadratus lumborum block;   Procedure: Transversus abdominis plane block;   Drug: Intravenous opioid Sponsor:   National Cancer Institute, Egypt Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
We have recently developed a highly accurate urine-based test, named Urodiag ®, associating FGFR3 mutation and DNA methylation assays for recurrence surveillance in patients with low-, intermediate-, and high-risk...
Source: BMC Medical Genetics - Category: Genetics & Stem Cells Authors: Tags: Technical advance Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | National Institute for Health and Clinical Excelle | Urology & Nephrology